1 | and its impact on | | | | | | | 8 | 1.38% |
2 | chorea story and its | | | | | | | 8 | 1.38% |
3 | ufuk from teva germany | | | | | | | 8 | 1.38% |
4 | on ufuk from teva | | | | | | | 8 | 1.38% |
5 | impact on ufuk from | | | | | | | 8 | 1.38% |
6 | its impact on ufuk | | | | | | | 8 | 1.38% |
7 | story and its impact | | | | | | | 8 | 1.38% |
8 | teva germany watch arthurs | | | | | | | 7 | 1.21% |
9 | from teva germany watch | | | | | | | 7 | 1.21% |
10 | qualitysafety a fully integrated | | | | | | | 4 | 0.69% |
11 | a fully integrated pharma | | | | | | | 4 | 0.69% |
12 | to qualitysafety a fully | | | | | | | 4 | 0.69% |
13 | committed to qualitysafety a | | | | | | | 3 | 0.52% |
14 | fully integrated pharma company | | | | | | | 3 | 0.52% |
15 | ernst pharmacia is a | | | | | | | 3 | 0.52% |
16 | pharmacia is a rapidly | | | | | | | 3 | 0.52% |
17 | holders can make advantages | | | | | | | 2 | 0.35% |
18 | best clinical products and | | | | | | | 2 | 0.35% |
19 | clinical products and alongside | | | | | | | 2 | 0.35% |
20 | products and alongside the | | | | | | | 2 | 0.35% |
21 | development of our pharma | | | | | | | 2 | 0.35% |
22 | franchise holders can make | | | | | | | 2 | 0.35% |
23 | to provide medical and | | | | | | | 2 | 0.35% |
24 | can make advantages and | | | | | | | 2 | 0.35% |
25 | is mindful to provide | | | | | | | 2 | 0.35% |
26 | at their own endeavor | | | | | | | 2 | 0.35% |
27 | development find out more | | | | | | | 2 | 0.35% |
28 | mindful to provide medical | | | | | | | 2 | 0.35% |
29 | provide medical and pharmaceutical | | | | | | | 2 | 0.35% |
30 | brands at their own | | | | | | | 2 | 0.35% |
31 | their own endeavor which | | | | | | | 2 | 0.35% |
32 | pharma franchise company pharma | | | | | | | 2 | 0.35% |
33 | we have massive list | | | | | | | 2 | 0.35% |
34 | is a rapidly growing | | | | | | | 2 | 0.35% |
35 | our products at different | | | | | | | 2 | 0.35% |
36 | selling our products at | | | | | | | 2 | 0.35% |
37 | growing association of pharmaceuticals | | | | | | | 2 | 0.35% |
38 | which consistently attempt to | | | | | | | 2 | 0.35% |
39 | distributors who are broadly | | | | | | | 2 | 0.35% |
40 | carry new opportunities to | | | | | | | 2 | 0.35% |